Back

How to manage arrhythmogenic cardiotoxicity and the risk of life-threatening ventricular arrhythmias and sudden cardiac death during cancer therapy?

21 June 2025 (10:10 - 10:25)
Organised by: Logo
Congress Presentation Part of: Protecting the heart during cancer therapy - How to manage the risk of sudden cardiac death? Heart Failure Open Access ESC Cardio-Oncology 2025 Council of Cardio-Oncology

About the speaker

Photo
Assistant Professor Dimitrios T Farmakis

National & Kapodistrian University of Athens, Athens (Greece)

3 More presentations in this session

Presentation thumbnail
Welcome and introduction
Professor I. Goldenberg (Rochester, US)
Video
Presentation thumbnail
Recovery of chemotherapy-related acute heart failure - what roles play current HF medication and the Wearable Cardioverter Defibrillator? - interactive case discussions
Doctor M. Canale (Lido Di Camaiore, IT)
Slides Video
Presentation thumbnail
Discussion and conclusion
Video

Access the full session

Session thumbnail
Protecting the heart during cancer therapy - How to manage the risk of sudden cardiac death?

The Event

Event poster

ESC Cardio-Oncology 2025

21 June 2025 10:10 CET
You may be interested in
thumbnail
Congress Session
2022 ESC Guidelines on cardio-oncology
27 August 2022
thumbnail
Congress Presentation
Anti-cancer drug-induced atrial and ventricular arrhythmias.
28 August 2022
thumbnail
Congress Presentation
Past, present, and future of cardio-oncology
20 June 2025
thumbnail
Congress Presentation
Management of arrhythmias in cancer patients
25 August 2023

ESC 365 is supported by

novartis Explore sponsored resources
novo-nordisk Explore sponsored resources

ESC 365 is supported by

novartis Explore sponsored resources
novo-nordisk Explore sponsored resources